Skip to content

Effect of Electronic Monitoring and Feedback on Adherence to Easyhaler Controller Medication in Patients With Asthma

Effect of Electronic Monitoring and Feedback on Adherence to Easyhaler Controller Medication in Patients With Asthma

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04869384
Acronym
eMOFEE
Enrollment
158
Registered
2021-05-03
Start date
2021-06-23
Completion date
2024-04-24
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

Effect of Electronic Monitoring and Feedback on Adherence to Easyhaler Controller Medication in Patients with Asthma

Interventions

OTHERReminders and feedback to improve adherence

Subjects will receive reminders and feedback to improve their adherence.

OTHERNo reminders and feedback to improve adherence

Subjects will not receive reminders and feedback to improve their adherence.

Sponsors

Orion Corporation, Orion Pharma
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Main inclusion Criteria: * written informed consent * male and female subjects with documented diagnosis of asthma * age 18 to 65 years * ACT score 19 or less at screening * treatment wih oral corticosteroids or hospital or emergency department admission due to asthma exacerbation within the past year * subject's able to use Easyhaler inhalers and comply with study requirements Main

Exclusion criteria

* recent (within 1 month) asthma exacerbation * concomitant major respiratory disease which may complicate the measurement of asthma control * \>20 pack-year history of smoking * recent upper or lower respiratory tract infection * pregnant or lactating female subjects

Design outcomes

Primary

MeasureTime frameDescription
Mean weekly adherence to controller medicationWeekly during each of the last 6 weeks of treatmentAdherence (percentage of doses taken of the doses prescribed) to controller medication during last six weeks of study

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026